Reports >
Life Sciences
>
Stents Market Report
Stents Market Report
First published: 10 October 2024 | Last updated: 28 May 2026 | Report Code: stents
Stents Market — USD $11 Billion in 2023, Growing to USD 23.85null by 2033 at 7.8% CAGR
This report provides a comprehensive analysis of the global stents market from 2023 to 2033, discussing market size, trends, and the competitive landscape. Insights into segmentation, regional performance, and future forecasts are also included.
Key Takeaways
- Global market value grows from $11.00 Billion (2023) to $23.85 Billion (2033) at a 7.8% CAGR over 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe rises from $3.61 Billion to $7.83 Billion over the forecast period, reflecting sustained demand for advanced stent technologies.
- Asia Pacific expands from $2.11 Billion to $4.58 Billion, driven by rising healthcare investment and device adoption.
- Key manufacturers include Boston Scientific Corporation, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, and Terumo Corporation.
Stents Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines market dynamics shaping the stents industry from 2023 to 2033. The market is valued at $11.00 Billion in 2023 and is forecast to reach $23.85 Billion by 2033, reflecting a 7.8% CAGR. Growth is supported by technological improvements in stent design and materials, rising prevalence of cardiovascular and peripheral vascular conditions, and increasing healthcare expenditure. The analysis segments the market by product type, application, material, end-user, and distribution channel, highlighting demand across hospitals, ambulatory surgery centers, and specialty clinics. Regional breakdowns present North America as the largest market and provide detailed figures for Europe, Asia Pacific, Latin America, and the Middle East and Africa. Competitive profiling includes major players and their strategic focuses. The report concludes with implications for manufacturers, payers, and healthcare providers considering regulatory pressures and innovation-led opportunities.
Key Growth Drivers
- Advances in stent materials and drug-delivery coatings improving clinical outcomes and broadening indications.
- Rising incidence of cardiovascular and vascular diseases increasing procedural volumes and demand for implants.
- Greater healthcare spending and improved access in multiple regions enabling wider adoption of interventional therapies.
- Expansion of hospital services and procedural capacity in cardiology and vascular care settings.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $11.00 Billion |
| CAGR (2023-2033) | 7.8% |
| 2033 Market Size | $23.85 Billion |
| Top Companies | Boston Scientific Corporation, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Terumo Corporation |
| Published Date | 10 October 2024 |
| Last Modified Date | 28 May 2026 |
Stents Market Overview
Customize Stents Market Report market research report
- ✔ Get in-depth analysis of Stents market size, growth, and forecasts.
- ✔ Understand Stents's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Stents
What is the Market Size & CAGR of Stents Market Report market in 2023?
Stents Industry Analysis
Stents Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Stents Market Report Market Analysis Report by Region
Europe Stents Market Report:
Europe grows from $3.61 Billion in 2023 to $7.83 Billion in 2033. Demand in the region is supported by established clinical infrastructure, adoption of advanced device technologies, and ongoing investments in cardiovascular care.Asia Pacific Stents Market Report:
Asia Pacific grows from $2.11 Billion in 2023 to $4.58 Billion in 2033. Increasing healthcare access, rising procedural volumes, and greater availability of interventional services underpin market growth in the region.North America Stents Market Report:
North America is largest regional market, rising from $3.62 Billion in 2023 to $7.85 Billion in 2033. Regional expansion is supported by higher healthcare investment, advanced interventional capabilities, and strong presence of leading manufacturers.South America Stents Market Report:
Latin America grows from $0.6 Billion in 2023 to $1.29 Billion in 2033. Growth reflects expanding healthcare services and incremental adoption of interventional cardiology and vascular procedures across national markets.Middle East & Africa Stents Market Report:
Middle East and Africa grows from $1.06 Billion in 2023 to $2.29 Billion in 2033. Improved healthcare infrastructure and growing awareness of cardiovascular treatments are contributing factors supporting market development.Tell us your focus area and get a customized research report.
Research Methodology
Stents Market Analysis By Product Type
Within the product type segmentation, metal stents hold a significant share, valued at $6.82 billion in 2023, projected to reach $14.78 billion by 2033. Drug-eluting stents, valued at $2.29 billion in 2023, are expected to achieve $4.96 billion by 2033. Bioresorbable stents also exhibit rapid growth, moving from $1.89 billion in 2023 to $4.10 billion in 2033.
Stents Market Analysis By Application
In terms of applications, the cardiology segment dominates with a market size of $6.21 billion in 2023, set to grow to $13.47 billion by 2033. The vascular application segment follows, expected to rise from $2.39 billion to $5.18 billion. Other critical applications include urology and gastroenterology.
Stents Market Analysis By End User
Hospitals play a critical role in the distribution of stents, accounting for 62% of the market share in 2023, with a market size of $6.82 billion. Ambulatory surgery centers follow closely, representing 20.82% share. The need for efficient surgical interventions drives demand in these facilities.
Stents Market Analysis By Material
Analyzing material types, bare metal stents have a significant presence in the market with a share of 62% and a size of $6.82 billion in 2023. Drug-eluting stents, made of polymers, also hold a substantial piece of the market, with forecasts suggesting continued demand in surgical settings.
Stents Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Stents Industry
Boston Scientific Corporation:
Boston Scientific is a leading medical device manufacturer known for its innovative stent technologies, particularly in cardiology and vascular interventions.Abbott Laboratories:
Abbott is a global healthcare leader, with a strong presence in the stents market, offering a range of drug-eluting and bare metal stents.Medtronic Plc:
Medtronic specializes in medical technology, providing advanced stenting solutions for various applications including drug-eluting and vascular stents.B. Braun Melsungen AG:
B. Braun offers a diverse portfolio of stenting solutions and emphasizes patient safety in its innovative designs.Terumo Corporation:
Terumo is well-known for its innovative vascular interventions and has a strong focus on delivering high-quality stenting products.We're grateful to work with incredible clients.
FAQs
What is the market size of the Stents market in 2023?
The market size in 2023 is $11.00 Billion, as reported for the global stents market for that year.
How big will the stents market be in 2033?
The market is projected to reach $23.85 Billion by 2033 based on the provided forecast figures.
What is CAGR for the stents market over the forecast period?
The compound annual growth rate is 7.8% for the period from 2023 to 2033.
Is there a single fastest Growing region in the Stents Market Report market?
No single fastest-growing region is stated for the Stents Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies named include Boston Scientific Corporation, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, and Terumo Corporation.
What are primary application areas for stents?
Primary applications include cardiology and vascular procedures, with additional uses in urology and gastroenterology as noted in segment data.
How are stents categorized by product type?
Product-type subsegments include Bare Metal Stents, Drug-Eluting Stents, and Bioresorbable Stents according to the segmentation details.
Why are material innovations important for stents?
Material innovations, such as metals, polymers, and composites, influence biocompatibility and functionality, supporting broader clinical adoption and improved outcomes.
What end Users are prominent for stent deployment?
End-user categories include hospitals, ambulatory surgery centers, and cardiology clinics, reflecting where stenting procedures are commonly performed.
Who conducted the research methodology for this report?
Research included primary interviews with industry experts and secondary review of company reports and publications, with data triangulation and validation.